Literature DB >> 2298099

Colorectal disease in spinal cord patients. An occult diagnosis.

W E Longo1, G H Ballantyne, I M Modlin.   

Abstract

Undiagnosed abdominal emergencies account for 10 percent of all fatalities among patients with spinal cord injuries. A large number of these emergencies involve the lower gastrointestinal tract. The purpose of this study is to bring attention to the occult nature of colorectal disease in spinal cord patients and to highlight the subtle, but characteristic, symptoms and signs that develop in these patients. The authors identified 13 spinal cord patients in whom a lesion developed in either the appendix, colon, rectum, or anus. The average age of all patients was 36.2 years. Trauma and multiple sclerosis were the most common etiology of spinal cord injury. The most common presenting symptoms were abdominal distention, vomiting, and constipation. The average delay in diagnosis of the colorectal disease was 35.8 hours. An 84% morbidity and 22% mortality were observed. This study indicates that any deviation from the normal lifestyle of the spinal cord patient should alert one to the possibility of visceral inflammation. Furthermore, close attention to the signs of autonomic dysreflexia or changes in spasticity, along with a thorough evaluation of the ill-appearing spinal cord patient, may uncover occult colonic or rectal disease.

Entities:  

Mesh:

Year:  1990        PMID: 2298099     DOI: 10.1007/bf02055542

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  2 in total

1.  Colonoscopy after spinal cord injury: a case-control study.

Authors:  B P Morris; T Kucchal; A N Burgess
Journal:  Spinal Cord       Date:  2014-11-04       Impact factor: 2.772

2.  Complicated fecal microbiota transplantation in a tetraplegic patient with severe Clostridium difficile infection.

Authors:  Thorsten Brechmann; Justyna Swol; Veronika Knop-Hammad; Jörg Willert; Mirko Aach; Oliver Cruciger; Wolff Schmiegel; Thomas A Schildhauer; Uwe Hamsen
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.